MarketPeel
Insider Trading Intelligence
AB

Andrew Booth

ABCL
CHIEF FINANCIAL OFFICER · ABCELLERA BIOLOGICS INC. · CIK 0001834411
FILING MIX · LIFETIME68%/32%
BUYS
15
SELLS
7
TOTAL VALUE
$32.85M
COMPANIES
1
ACTIVE SINCE
Jun 2021
HOLDINGS NOW
445,600
AVG SELL PX
$25.50
TRADE KIND
SHOWING 22 / 22
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
6 backtested trades · 8 horizons · 3 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Andrew Booth, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d6+66.67%+3.20%+0.31%+2.90%-0.79%
14d6+50.00%-0.72%+0.87%-1.59%-2.57%
30d6+50.00%-2.72%+0.20%-2.92%-5.08%
60d6+66.67%+3.61%+2.93%+0.67%-7.81%
90d6+50.00%+5.73%+3.47%-5.91%-27.93%
180d6(1 pending)+40.00%-21.51%-1.99%-19.53%-42.51%
1y6(1 pending)+20.00%-28.44%+1.10%-29.53%-21.14%
2y6(1 pending)+20.00%-66.11%+15.92%-82.03%-75.31%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ABCL · 445,600 shares · as of Jun 3, 2026
02,187,9624,375,9256,563,8878,751,84920222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 15 buys / 7 sellsCOVERAGE · 21 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ABCL
ABCELLERA BIOLOGICS INC.
PURCHASE
Chief Financial Officer
250,000$0.19$47.5K445,600Jun 3, 2026Jun 3, 2026View →
ABCL
ABCELLERA BIOLOGICS INC.
SALE
Chief Financial Officer
250,0008,501,849Jun 3, 2026Jun 3, 2026View →
ABCL
ABCELLERA BIOLOGICS INC.
PURCHASE
Chief Financial Officer
42,600$3.42$145.7K195,600Feb 27, 2026Feb 27, 2026View →
ABCL
ABCELLERA BIOLOGICS INC.
PURCHASEGRANT
Stock grant
808,8988,751,849Jan 1, 2026Jan 5, 2026View →
ABCL
ABCELLERA BIOLOGICS INC.
PURCHASEGRANT
Stock grant
1,352,0547,942,951Jan 1, 2025Jan 3, 2025View →
ABCL
ABCELLERA BIOLOGICS INC.
PURCHASEGRANT
Stock grant
770,4166,590,897Jan 14, 2024Jan 16, 2024View →
ABCL
ABCELLERA BIOLOGICS INC.
PURCHASE
Chief Financial Officer
14,500$6.85$99.3K153,000May 26, 2023May 26, 2023View →
ABCL
ABCELLERA BIOLOGICS INC.
SALEGRANT
Gift
50,000138,500Dec 20, 2022Dec 22, 2022View →
ABCL
ABCELLERA BIOLOGICS INC.
SALE
Chief Financial Officer
50,0005,820,481Dec 20, 2022Dec 22, 2022View →
ABCL
ABCELLERA BIOLOGICS INC.
PURCHASE
Chief Financial Officer
50,000$0.19$9.5K188,500Dec 20, 2022Dec 22, 2022View →
ABCL
ABCELLERA BIOLOGICS INC.
PURCHASEGRANT
Stock grant
485,6615,870,481Dec 1, 2022Dec 5, 2022View →
ABCL
ABCELLERA BIOLOGICS INC.
PURCHASE
Chief Financial Officer
85,000$5.79$492.1K138,500May 12, 2022May 16, 2022View →
ABCL
ABCELLERA BIOLOGICS INC.
PURCHASE
Chief Financial Officer
500,000$0.32$160.0K553,500Dec 10, 2021Dec 10, 2021View →
ABCL
ABCELLERA BIOLOGICS INC.
SALE
Chief Financial Officer
500,0005,384,820Dec 10, 2021Dec 10, 2021View →
ABCL
ABCELLERA BIOLOGICS INC.
PURCHASEGRANT
Stock grant
406,0205,884,820Dec 7, 2021Dec 9, 2021View →
ABCL
ABCELLERA BIOLOGICS INC.
PURCHASE
Chief Financial Officer
14,000$14.61$204.5K130,959Nov 11, 2021Nov 15, 2021View →
ABCL
ABCELLERA BIOLOGICS INC.
PURCHASE
Chief Financial Officer
53,500$14.74$788.6K53,500Nov 11, 2021Nov 15, 2021View →
ABCL
ABCELLERA BIOLOGICS INC.
SALE
Chief Financial Officer
1,200,000$25.50$30.60M0Jun 9, 2021Jun 10, 2021View →
ABCL
ABCELLERA BIOLOGICS INC.
PURCHASE
Chief Financial Officer
600,000$0.19$114.0K600,000Jun 7, 2021Jun 9, 2021View →
ABCL
ABCELLERA BIOLOGICS INC.
SALE
Chief Financial Officer
600,000300,000Jun 7, 2021Jun 9, 2021View →
ABCL
ABCELLERA BIOLOGICS INC.
SALE
Chief Financial Officer
600,0004,950,000Jun 7, 2021Jun 9, 2021View →
ABCL
ABCELLERA BIOLOGICS INC.
PURCHASE
Chief Financial Officer
600,000$0.32$192.0K1,200,000Jun 7, 2021Jun 9, 2021View →
Other insiders · ABCL
Loading peer insiders…
About this filer
CIK 0001834411
ROLE
Chief Financial Officer
PRIMARY
ABCL
COMPANIES
1
ACTIVE SINCE
Jun 2021
MARKETPEEL · /INSIDER/0001834411DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback